STOCK TITAN

Ametek, Inc. Form 4 Filings

AME NYSE

Every Form 4 that Ametek, Inc. (AME) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow AME and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AME filings page.

Rhea-AI Summary

AMETEK Inc. director Nick L. Stanage reported a purchase of 4,000 shares of AMETEK common stock on 2026-08-11 at $255.85 per share in a purchase described as an open market or private transaction. Following this buy, he directly owns 4,760 shares of common stock.

Rhea-AI Summary

AMETEK executive David F. Hermance, President – Electromechanical, exercised stock options for 6,608 shares of common stock at an exercise price of $85.45 per share and on the same date sold 6,608 shares at $254.00 per share. The options, received as employment compensation, became exercisable in three equal annual installments beginning on May 9, 2020. Following the reported transactions, Hermance reports direct holdings of 993 shares of Common Stock/SERP and indirect holdings of 484 shares through a 401(k) plan.

Rhea-AI Summary

AMETEK's chief administrative officer Ronald J. Oscher reported internal ownership changes rather than open-market trading. The filing shows a Code J restructuring involving 39,954 shares of common stock moved to a trust described as being held by him as trustee, with no price reported.

After these transactions, he holds 2,887 common shares directly and 39,954 shares indirectly through the trust, plus 4,897 common stock units in a SERP account and 916 shares through a 401k plan. The activity reflects a transfer to a trust, not a purchase or sale.

Rhea-AI Summary

Stanage Nick L reported acquisition or exercise transactions in this Form 4 filing.

AMETEK director Nick L. Stanage received a grant of 760 shares of common stock as restricted stock. The award was issued on May 7, 2026 under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan at a reference value of $234.73 per share.

After this grant, Stanage directly holds 760 shares of AMETEK common stock reported in this filing. This is a compensation-related stock award rather than an open-market purchase or sale.

Rhea-AI Summary

AMETEK director Thomas A. Amato reported an open-market sale of 530 shares of Common Stock at $216.78 per share. After this sale, he held 4,480 shares directly. The filing also shows two Code J transactions of 500 shares each, reclassifying holdings between direct ownership and a trust reported as indirect ownership, resulting in 3,980 shares held directly and 7,000 shares held indirectly by a trust for which he serves as trustee.

Rhea-AI Summary

AMETEK chief commercial officer Emanuela Speranza exercised restricted stock units into common stock in two transactions and had shares withheld to cover taxes. On March 19, 2026, 230 restricted stock units were converted into 230 common shares, with 104 shares withheld at $211.50 per share for taxes.

On March 22, 2026, a further 344 restricted stock units were converted into 344 common shares, with 155 shares withheld at $209.37 per share for taxes. After these compensation-related transactions, she directly holds 30,516 AMETEK common shares. Footnotes note remaining restricted stock units vesting on March 19, 2027.

Rhea-AI Summary

AMETEK Inc. chief executive David A. Zapico reported routine tax-related share withholdings. On March 22, 2026, 2,092 shares of common stock were withheld at $209.37 per share to cover tax obligations. On March 19, 2026, an additional 1,412 shares were withheld at $211.50 per share for the same purpose.

After these dispositions for taxes, Zapico continued to directly hold 343,595 shares of AMETEK common stock, and a separate holding line shows 24,058 units titled "Common Stock/ Serp" as of March 19, 2026.

Rhea-AI Summary

AMETEK INC executive Tony J. Ciampitti, President of Electronic Instruments, reported two small tax-related share dispositions in company stock. A total of 435 common shares were withheld on March 19 and March 22, 2026 at prices of $211.50 and $209.37 per share to cover tax obligations, not open-market sales. After these withholdings, he directly holds 55,754 common shares, plus 9,465 common stock/SERP units and 2,776 shares held indirectly through a 401(k) plan.

Rhea-AI Summary

AMETEK Senior VP and Controller Robert Amodei reported routine share disposals related to tax withholding, not open-market trading. On March 22, 63 shares of common stock were withheld at $209.37 per share, and on March 19, 48 shares were withheld at $211.50 per share to cover tax obligations.

These transactions reduced his directly held common stock by a combined 111 shares, leaving 44,110 common shares held directly after the later transaction. The filing also shows holdings of 711 units under a Common Stock/SERP arrangement and 3,149 shares held indirectly through a 401(k) Plan.

Rhea-AI Summary

AMETEK INC/ executive John Wesley Hardin reported routine tax-related share dispositions. On March 22, 2026, 279 shares of common stock were withheld at $209.37 per share, and on March 19, 2026, 178 shares were withheld at $211.50 per share to pay taxes. These are coded as F transactions and described as payment of tax liability by delivering securities, not open‑market sales. Following these events, he holds 67,859 common shares directly, 23,159 Common Stock/Serp units directly, and 526 shares indirectly through a 401k plan.

Rhea-AI Summary

AMETEK executive David F. Hermance reported routine share dispositions related to tax withholding, not open-market sales. On March 19 and 22, 2026, a total of 469 shares of common stock were withheld to pay taxes, leaving 42,509 shares held directly, plus additional 401(k) and SERP holdings.

Rhea-AI Summary

AMETEK executive Thomas C. Marecic reported routine tax-related share withholdings, not open-market trades. On March 19, 2026, 186 shares of Common Stock were withheld at $211.50 per share, and on March 22, 2026, 294 shares were withheld at $209.37 per share to cover tax obligations.

After these transactions, he directly holds 45,053 shares of Common Stock, plus 13,644 Common Stock/Serp units, 3,048 shares through a 401(k) plan, and 348 shares indirectly held by his wife.

Rhea-AI Summary

AMETEK's Chief Administrative Officer Ronald J. Oscher reported two tax-related share withholdings of the company’s common stock. On March 22, 2026, 266 shares were withheld at $209.37 per share, and on March 19, 2026, 169 shares were withheld at $211.50 per share.

Both transactions were coded as tax-withholding dispositions, meaning shares were delivered to cover tax obligations rather than sold in the open market. After these events, Oscher directly held 42,841 common shares, plus 4,897 common stock/Serp units and 916 shares held indirectly through a 401k plan.

Rhea-AI Summary

AMETEK Executive VP and CFO Dalip Puri reported two small share dispositions that were solely to cover tax obligations, not open-market sales. On March 19, 2026, 237 shares of common stock were withheld at $211.50 per share. On March 22, 2026, a further 67 shares were withheld at $209.37 per share. In total, 304 shares were used for tax withholding, and Puri now directly holds 11,528 shares of AMETEK common stock following these routine transactions.

Rhea-AI Summary

AMETEK chief commercial officer Emanuela Speranza reported compensation-related equity awards and a routine option exercise. She received stock options covering 1,790 shares of common stock at an exercise price of $212.77 per share, vesting in three equal annual installments beginning on March 18, 2027, and expiring on March 18, 2036.

She was also granted 570 restricted stock units (RSUs), vesting in three equal annual installments beginning on March 18, 2027. Separately, 296 RSUs that vest in three equal annual installments beginning March 19, 2026 were converted into 296 shares of common stock, and 134 shares were withheld at $212.77 per share to satisfy tax obligations. After these transactions, she directly holds 30,201 shares of common stock, along with 1,790 options and 594 RSUs.

Rhea-AI Summary

AMETEK, Inc. chief executive officer David A. Zapico reported equity compensation changes. He received stock options for 47,230 shares of Common Stock at an exercise price of $212.77 per share, which will vest in three equal annual installments beginning on March 18, 2027.

He was also granted 11,930 shares of restricted Common Stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. To cover tax obligations on this award, 1,604 shares were withheld. Following these grants and tax withholding, he holds 347,099 shares of Common Stock directly and 24,058 Common Stock/SERP units.

Rhea-AI Summary

AMETEK chief administrative officer Ronald J. Oscher reported routine equity compensation and related tax withholding. He received stock options for 4,110 shares of common stock at an exercise price of $212.77 per share, expiring on March 18, 2036, which vest in three equal annual installments starting March 18, 2027. He also received 1,300 shares of restricted common stock at $212.77 per share under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. To cover taxes, 229 shares of common stock were withheld, leaving him with 43,276 shares of common stock directly held, plus additional holdings of 4,897 common stock/ SERP units and 916 shares in a 401(k) plan.

Rhea-AI Summary

AMETEK executive Thomas C. Marecic, President – Electronic Instruments, received new equity awards in the form of stock options and restricted shares. He was granted stock options on 3,930 shares of common stock at an exercise price of $212.77 per share, expiring in 2036, which will become exercisable in three equal annual installments beginning on March 18, 2027. He also acquired 1,240 shares of common stock as a restricted stock award issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. To cover taxes on the equity compensation, 253 shares of common stock were withheld, which is treated as a disposition but not an open-market sale. Following these transactions, Marecic directly owns 45,533 shares of common stock, along with additional holdings through a 401(k) plan and shares held by his wife.

Rhea-AI Summary

AMETEK Executive VP and CFO Dalip Puri reported equity compensation awards and related tax withholding. He received stock options for 11,960 shares of Common Stock at an exercise price of $212.7700 per share, issued under the company’s 2020 Omnibus Incentive Compensation Plan. These options become exercisable in three equal annual installments beginning on March 18, 2027 and expire on March 18, 2036. He was also granted 3,780 shares of Common Stock, with 335 shares withheld to cover taxes, leaving 11,832 shares of Common Stock held directly after the transactions.

Rhea-AI Summary

AMETEK executive David F. Hermance, President – Electromechanical, reported routine equity compensation awards. He received stock options for 3,930 shares of common stock at an exercise price of $212.7700 per share, which will become exercisable in three equal annual installments beginning on March 18, 2027 and expire on March 18, 2036.

Hermance was also granted 1,240 shares of restricted common stock at $212.7700 per share, issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Of these, 248 shares were withheld to cover tax liabilities, leaving 42,978 common shares held directly after the transactions, plus 484 shares held indirectly through a 401(k) plan and 993 common stock SERP units.

Rhea-AI Summary

AMETEK executive John Wesley Hardin reported compensation-related equity awards rather than open-market trades. He received stock options for 4,290 shares of Common Stock at an exercise price of $212.7700 per share, which become exercisable in three equal annual installments beginning on March 18, 2027 and expire on March 18, 2036.

He also acquired 1,360 shares of Common Stock as restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Of these, 237 shares were withheld to pay taxes, leaving 68,316 Common shares held directly after the transactions, plus 526 shares held indirectly through a 401k plan and 23,159 Common Stock/SERP units held directly.

Rhea-AI Summary

AMETEK Senior VP and Controller Robert Amodei received new equity awards. He was granted stock options for 1,130 shares of common stock at an exercise price of $212.77 per share. These options vest in three equal annual installments beginning on March 18, 2027 and expire on March 18, 2036.

Amodei also received 360 shares of common stock at $212.77 per share as restricted stock under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Of these, 69 shares were withheld to cover taxes, with the remainder added to his direct holdings, which total 44,221 common shares after the transactions. He also holds 3,149 shares indirectly through a 401(k) plan and 711 shares in a Common Stock SERP account.

Rhea-AI Summary

AMETEK executive Tony J. Ciampitti, President of Electronic Instruments, received new equity awards. He was granted stock options for 4,110 shares of common stock at an exercise price of $212.77 per share, which become exercisable in three equal annual installments beginning on March 18, 2027. He also received 1,300 shares of restricted common stock valued at $212.77 per share, while 229 shares were withheld to pay taxes. Following these transactions, he directly holds 56,189 shares of common stock, plus 4,110 stock options, with additional holdings of 9,465 units in a SERP account and 2,776 shares through a 401(k) plan.

Rhea-AI Summary

Oberton Karleen Marie reported acquisition or exercise transactions in this Form 4 filing.

AMETEK Inc. director Karleen Marie Oberton received a grant of 950 shares of Common Stock, constituting restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. The award was valued at $212.77 per share on the grant date. Following this grant, she directly holds 5,640 shares.

Rhea-AI Summary

AMATO THOMAS A reported acquisition or exercise transactions in this Form 4 filing.

AMETEK director Thomas A. Amato received a grant of 950 shares of restricted common stock, valued at $212.77 per share, under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. This is a compensation-related award rather than an open-market purchase.

After the grant, he directly holds 5,010 common shares. The filing also shows an additional 6,500 common shares held indirectly by a trust, giving him both direct and indirect exposure to AMETEK stock.

Rhea-AI Summary

AMETEK Inc. director Stefany Suzanne received a grant of 950 shares of Common Stock as a restricted stock award. The award was issued at a value of $212.77 per share under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Following this compensation-related acquisition, she directly holds 5,030 AMETEK shares.

Rhea-AI Summary

AMETEK Inc. director Dean Seavers reported an equity award of company stock. On this Form 4, he acquired 950 shares of AMETEK common stock as a grant or award valued at $212.77 per share. The shares constitute restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.

Following this award, Seavers directly holds 5,600 shares of AMETEK common stock. This transaction reflects compensation in stock rather than an open-market purchase.

Rhea-AI Summary

AMETEK director Anthony James Conti received a grant of company stock as compensation. He acquired 950 shares of AMETEK common stock on March 18, 2026, recorded at $212.77 per share, as restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Following this award, he directly owns 30,298 common shares. This was a compensation-related grant, not an open-market purchase.

Rhea-AI Summary

Carpenter Tod E. reported acquisition or exercise transactions in this Form 4 filing.

AMETEK director Tod E. Carpenter received a grant of 950 shares of common stock, valued at $212.77 per share, as equity compensation. The award is restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan and is held directly.

After this grant, Carpenter directly owns 10,480 AMETEK common shares. Restricted stock generally vests over time or upon meeting conditions, aligning a director’s interests with long-term shareholder value rather than representing an open-market purchase.

Rhea-AI Summary

AMETEK director Gretchen W. McClain received 950 shares of common stock as a restricted stock award at $212.77 per share under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. This is a compensation-related grant, not an open‑market purchase.

McClain now holds 18,981 shares of common stock directly after this award. She also acquired 52 additional common stock units through dividend reinvestments in the Deferred Compensation Plan, bringing her deferred compensation holdings to 3,199 units. These transactions reflect routine equity compensation and plan reinvestments rather than discretionary trading.

Rhea-AI Summary

AMETEK director Thomas A. Amato reported two Form 4 “other” transactions (code J) involving 6,500 shares of common stock each at a stated price of $0.00 per share. After these entries, he holds 4,060 shares directly and 6,500 shares indirectly through a trust where he serves as trustee.

Rhea-AI Summary

AMETEK Senior VP and Controller Robert Amodei reported routine equity compensation activity. He acquired 279 shares of common stock at $0.0000 per share as a grant, reflecting the settlement of PRSUs awarded on March 22, 2023. To cover related tax obligations, 96 shares were disposed of at $233.3300 per share through a tax-withholding transaction. After these transactions, he directly held 43,930 shares of common stock, along with 711 common stock/Serp units and 3,149 shares held indirectly through a 401(k) plan.

Rhea-AI Summary

AMETEK chief commercial officer Emanuela Speranza reported mixed equity transactions in company common stock. She acquired 1,399 shares on a grant/award basis at a stated price of $0.0000 per share, reflecting the settlement of performance‑based restricted stock units awarded on March 22, 2023.

On the same date, 630 shares at $233.33 per share were disposed of through a tax‑withholding transaction to cover related tax obligations. After these transactions, she directly held 30,039 shares of AMETEK common stock.

Rhea-AI Summary

AMETEK Executive Vice President and CFO Dalip Puri reported mixed equity transactions in company common stock. He acquired 373 shares on a grant or award basis, reflecting settlement of performance-based restricted stock units (PRSUs) originally awarded on March 22, 2023, increasing his direct holdings before related tax actions.

On the same date, 103 shares were disposed of through a tax-withholding transaction at a price of $233.33 per share to cover associated tax obligations. After these transactions, Puri directly owned 8,387 shares of AMETEK common stock, showing the net equity position following the PRSU settlement and tax withholding.

Rhea-AI Summary

AMETEK executive Tony J. Ciampitti reported several equity-related transactions on February 17, 2026. He received a grant of 2,755 shares of common stock and 733 shares were delivered at $233.3300 per share to satisfy tax obligations. The Form 4 also notes non-priced other transactions involving 63 shares in a SERP account and 16 shares in a 401(k) plan. After these events, he directly holds 55,118 shares of AMETEK common stock.

Rhea-AI Summary

AMETEK executive John Wesley Hardin reported several routine equity transactions. He received a grant of 2,887 shares of common stock on February 17, 2026 as the settlement of performance-based restricted stock units awarded on March 22, 2023, bringing this direct holding to 68,122 shares before tax effects.

To cover related tax obligations, 929 common shares were withheld at a price of $233.33 per share, leaving 67,193 common shares held directly afterward. In addition, 75 units were credited through dividend reinvestments in a Supplemental Executive Retirement Plan and 1 unit through dividend reinvestment in a 401(k) plan, bringing that plan’s balance to 526 units.

Rhea-AI Summary

AMETEK executive Thomas C. Marecic reported several routine equity transactions. He received a grant of 2,755 shares of common stock from the settlement of previously awarded PRSUs, while 798 shares were withheld to pay related taxes. Additional 91 shares in a Supplemental Executive Retirement Plan and 19 shares in a 401(k) Plan were acquired through dividend reinvestments. He also reported indirect holdings of 348 common shares held by his wife.

Rhea-AI Summary

AMETEK executive David F. Hermance, President – Electromechanical, reported several equity-related transactions in company stock. He acquired 2,652 shares of common stock through the settlement of performance-based restricted stock units awarded on March 22, 2023, increasing his direct holdings to 42,817 shares.

To cover related tax obligations, 831 shares of common stock were withheld at a price of 233.3300 per share, reducing his direct holdings to 41,986 shares. In addition, 6 common stock equivalents were added through dividend reinvestments in the Supplemental Executive Retirement Plan and 3 units were added via dividend reinvestments in the 401(k) Plan, bringing his 401(k) position to 484 units.

Rhea-AI Summary

AMETEK chief administrative officer Ronald J. Oscher reported several equity-related transactions in company stock. He received a grant of 2,755 shares of common stock on February 17, 2026 in settlement of PRSUs originally awarded on March 22, 2023, bringing his directly held common stock to 42,981 shares before tax withholding.

To cover taxes, 776 common shares were withheld at a price of $233.33 per share, leaving 42,205 directly owned shares. In addition, 32 units were added through dividend reinvestments under the Supplemental Executive Retirement Plan and 6 units through dividend reinvestments in a 401(k) plan, resulting in 4,897 SERP-related units and 916 401(k) plan units.

Rhea-AI Summary

AMETEK chief executive officer David A. Zapico reported several equity-related transactions in the company’s stock. He acquired 32,519 shares of common stock at no cost through the settlement of performance-based restricted stock units awarded on March 22, 2023. To cover associated tax obligations, 12,797 shares were disposed of at a price of $233.33 per share through share withholding rather than an open-market sale. In a separate plan-related adjustment, 76 additional common stock equivalents were credited through dividend reinvestments under the Supplemental Executive Retirement Plan.

Rhea-AI Summary

AMETEK Inc. chief commercial officer Julie A. Speranza reported equity award vesting and related tax withholding transactions. On March 21, 2025, 404 shares of common stock were acquired at an exercise price of $0 through the vesting of restricted stock units, and 182 shares were disposed of at $174.52 per share to cover taxes. On March 22, 2025, a further 343 shares were acquired at $0, with 155 shares disposed of at $174.52 per share for tax withholding, as noted in the filing.

Following these transactions, Table I shows 31,970 shares of AMETEK common stock held directly. The footnotes state that the restricted stock units vest in three equal annual installments starting on March 19, 2025 and March 22, 2024, and that Ms. Speranza owned 29,270 shares of common stock as of the date this amendment was filed.

Rhea-AI Summary

AMETEK’s chief commercial officer, Giovanna M. Speranza, reported equity awards and related share movements. On March 18, 2025 she received 890 restricted stock units and 2,720 stock options, each tied to AMETEK common stock at an exercise price of $176.08.

On March 19, 2025, 230 restricted stock units were converted into common stock at $0, and 104 of those shares were withheld at $177.07 per share to cover taxes. After these transactions she directly owned 31,560 AMETEK common shares, plus 890 restricted stock units, 2,720 stock options, and 460 additional restricted stock units subject to vesting schedules beginning March 18, 2026 and March 22, 2024.

Rhea-AI Summary

AMETEK Inc. director reports stock gift

A director of AMETEK Inc. reported a disposition of 1,250 shares of AMETEK common stock on 12/30/2025 coded as "G," indicating a gift transaction. The shares were transferred at a reported price of $0, consistent with a non-cash gift rather than a market sale. Following this transaction, the director beneficially owns 4,690 shares of AMETEK common stock in direct ownership.

Rhea-AI Summary

AMETEK Inc. (AME) senior vice president and comptroller reported a small gift of company stock. On 12/26/2025, the officer transferred 19 shares of Common Stock in a transaction coded “G” (gift) at a reported price of $0 per share.

After this transaction, the officer beneficially owns 22,097 shares held directly in a 401(k) plan, 3,441 shares held indirectly through a 401(k) plan common stock/SERP arrangement, and 3,283 shares held directly outside those plans. The filing reports no derivative securities.

Rhea-AI Summary

AMETEK Inc. officer reports option exercise and share sale. A senior vice president and comptroller exercised stock options for 6,388 shares of AMETEK common stock on 12/22/2025 at an exercise price of $85.45 per share and immediately sold 6,388 shares on the same date. The reported sale price is $205.0548 per share, with actual sale prices ranging from $204.57 to $205.49. After these transactions, the reporting person holds 22,116 AMETEK shares directly and 3,441 shares indirectly through a 401(k) plan. The underlying stock options, which were scheduled to become exercisable in three equal annual installments beginning on May 9, 2020, now show a remaining balance of zero and had an expiration date of May 9, 2029.

Rhea-AI Summary

AMETEK, Inc. reported an insider transaction by its Electronic Instruments president involving company common stock on 12/15/2025. The officer exercised stock options for 14,310 shares of common stock at an exercise price of $63.37 per share; these options became exercisable in three equal annual installments beginning on March 20, 2021.

On the same date, the officer sold 14,310 shares of AMETEK common stock at a price of $202.1131 per share, with sale prices ranging from $202.00 to $202.44. After these transactions, the officer directly owned 42,589 shares, held 3,029 shares through a 401k plan, 348 shares held by a spouse, and 13,553 shares of Common Stock/SERP, with no stock options remaining.

Rhea-AI Summary

AMETEK Inc. chief executive officer and director David A. Zapico reported gifts and a trust sale of company stock. On 12/12/2025, he made a gift of 3,514 shares of AMETEK common stock and a separate gift of 28,390 shares to a family trust. Following these gifts, he directly held 317,051 shares of AMETEK stock.

The family trust, for which Zapico disclaims beneficial ownership, then sold 28,390 shares of AMETEK common stock on the same date at an average price of $201.76 per share, with individual trades ranging from $201.12 to $202.00. After this transaction, the trust held no AMETEK shares, while Zapico continued to report substantial direct ownership.

Rhea-AI Summary

AMETEK, Inc. (AME) reported an insider transaction by its Chief Executive Officer and director. On 11/25/2025, the reporting person exercised 88,000 stock options at an exercise price of $63.37 per share, acquiring the same number of AMETEK common shares.

On the same date, the insider sold an aggregate of 88,000 common shares in three transactions: 7,432 shares at a weighted average price of $194.89, 25,815 shares at $195.82, and 54,753 shares at $196.86, with detailed price ranges provided in the notes. After these transactions, the insider directly owned 348,955 shares of common stock, plus 23,982 common stock/ SERP units and 11,080 stock options.

Rhea-AI Summary

AMETEK, Inc. (AME) disclosed an insider transaction by its Chief Commercial Officer. On 11/12/2025, the officer sold 2,700 shares of common stock at a price of $200 per share, coded “S” for sale.

Following the transaction, the officer beneficially owned 28,293 shares, reported as direct ownership. No derivative securities were listed in the filing.

Rhea-AI Summary

AMETEK (AME) insider transaction: The company’s Chief Administrative Officer reported option exercises and an open‑market sale on 10/31/2025. He exercised 14,310 options at $63.37 and 11,980 options at $85.45, then sold 26,290 shares at an average price of $200.0459, per the filing.

Following these transactions, beneficial ownership stood at 40,226 shares held directly, 910 shares held indirectly via a 401(k) plan, and 4,865 shares shown as direct under a SERP-related line item. The sale price range was $200.00 to $200.19, with details available upon request.